Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Pranav K. Gandhi"'
Autor:
Shannon L. Reynolds, Sameer R. Ghate, Richard Sheer, Pranav K. Gandhi, Chad Moretz, Cheng Wang, Stephen Sander, Mary E. Costantino, Srinivas Annavarapu, George Andrews
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Novel oral anticoagulants (NOAC) such as dabigatran, when compared to warfarin, have been shown to potentially reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) together with lower healthcare resou
Externí odkaz:
https://doaj.org/article/155ea9dc7e534a27aa8cf5f05b5317cc
Autor:
Odette S Reifsnider, Anuraag R Kansal, Pranav K Gandhi, Lael Cragin, Sarah B Brand, Egon Pfarr, Kyle Fahrbach, Anastasia Ustyugova
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Empagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, is approved in the USA to reduce risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus (T2DM) and established CV disease, based on EMPA-REG OUTCOME
Externí odkaz:
https://doaj.org/article/966d9585cb5946edb1ec8a1250454bac
Autor:
Pranav K Gandhi, Lindsay A Thompson, Sanjeev Y Tuli, Dennis A Revicki, Elizabeth Shenkman, I-Chan Huang
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107771 (2014)
The purpose of this study was to develop item banks by linking items from three pediatric health-related quality of life (HRQoL) instruments using a mixed methodology. Secondary data were collected from 469 parents of children aged 8-16 years. The In
Externí odkaz:
https://doaj.org/article/530dc2cf4c8a4d96a3413c291ac1cf94
Autor:
Kyle Fahrbach, Egon Pfarr, Odette Reifsnider, Anastasia Ustyugova, Anuraag R. Kansal, Pranav K. Gandhi, Lael Cragin, Sarah Brand
Publikováno v:
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
IntroductionEmpagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, is approved in the USA to reduce risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus (T2DM) and established CV disease, based on EMPA-REG OUTCOME (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee5a9775f8c69066d4724fbc7bb9bad
https://pubmed.ncbi.nlm.nih.gov/33941549
https://pubmed.ncbi.nlm.nih.gov/33941549
Autor:
Sharash Shetty, Brent A. Williams, Jeanine M. Cordova, James C. Blankenship, Pranav K. Gandhi, Stephen J Voyce
Publikováno v:
Canadian Journal of Diabetes. 45:650-658.e2
Objectives In type 2 diabetes (T2D), the most common causes of death are cardiovascular (CV) related, accounting for >50% of deaths in some reports. As novel diabetes therapies reduce CV death risk, identifying patients with T2D at highest CV death r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb4b61ca9250fd5aa96b1e05eb6762d0
https://doi.org/10.1016/j.jcjd.2021.01.009
https://doi.org/10.1016/j.jcjd.2021.01.009
Autor:
Cheng Wang, Nan Qiao, Anuraag R. Kansal, Kristen A Deger, Siyang Peng, Anastasia Ustyugova, Pranav K. Gandhi
Publikováno v:
Current Medical Research and Opinion. 34:55-63
Dabigatran and rivaroxaban have been approved by the US FDA to reduce the risk of stroke and systemic embolism in non-valvular atrial fibrillation (NVAF) patients. Newly published real-world evidence based on the US population found that elderly Medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24378c1b39eaef249e46264e71e7c425
https://doi.org/10.1080/03007995.2017.1375470
https://doi.org/10.1080/03007995.2017.1375470
Autor:
Heather E. Gross, Carolyn E. Schwartz, I-Chan Huang, Darren A. DeWalt, Bryce B. Reeve, Pranav K. Gandhi
Publikováno v:
Quality of Life Research. 25:1349-1359
To examine item-level response shift associated with the change in asthma-related health state (i.e., change in asthma control status and global rating of change (GRC) in breathing problems).Study sample comprised 238 asthmatic children who were betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c217f32aae65d964705228b1af140afe
https://doi.org/10.1007/s11136-016-1290-x
https://doi.org/10.1007/s11136-016-1290-x
Autor:
Pranav K. Gandhi, Brent A. Williams
Publikováno v:
Diabetes. 67
Type 2 diabetes mellitus (T2DM) is strongly associated with future cardiovascular (CV) events, including heart failure (HF) and its sequelae such as hospitalization (HFH) and death. Identifying T2DM patients at highest risk of HFH may be clinically v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1c5cf7a1763082e0ad9184f4de1a4f
https://doi.org/10.2337/db18-409-p
https://doi.org/10.2337/db18-409-p
Autor:
Zhenxiang Zhao, Todd Prewitt, Kimberly G. Brodovicz, Yong Li, Pranav K. Gandhi, Radhika Nair, Chad Moretz, Michele Mackenzie, Samaneh Kalirai, Bradley H. Curtis, Yunus Meah
Publikováno v:
Diabetes. 67
Understanding the natural progression of type 2 diabetes mellitus (T2DM) is crucial in determining the appropriate approaches to care and effective management among these patients. Patients with a diagnosis for T2DM between January 2012 to December 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5bb104f31aa01c63845a3dffbbef1cd
https://doi.org/10.2337/db18-1659-p
https://doi.org/10.2337/db18-1659-p
Autor:
Yong Li, Chad Moretz, Cheng Wang, Prachi Arora, Stephen Sander, Pranav K. Gandhi, Srinivas Annavarapu, George Andrews
Publikováno v:
Journal of comparative effectiveness research. 7(7)
Factors influencing differences in persistence between dabigatran and warfarin in patients with nonvalvular atrial fibrillation (NVAF) remain unclear. Aim: Compare differences in persistence between new dabigatran and warfarin users in patients newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b228ad739de9f4e486ae25b57494176d
https://pubmed.ncbi.nlm.nih.gov/29808717
https://pubmed.ncbi.nlm.nih.gov/29808717